Your browser doesn't support javascript.
loading
Relationship between lymphovascular invasion and molecular subtypes in invasive breast cancer.
Morkavuk, Sevket Baris; Güner, Murat; Çulcu, Serdar; Eroglu, Aydan; Bayar, Sancar; Ünal, Ali Ekrem.
Afiliação
  • Morkavuk SB; Department of Surgical Oncology, Ankara City Hospital, Ankara, Turkey.
  • Güner M; Department of General Surgery, Usak Research and Training Hospital, Usak, Turkey.
  • Çulcu S; Department of General Surgery, Dr. Abdurrahman Yurtaslan Research and Training Hospital, Ankara, Turkey.
  • Eroglu A; Department of Surgical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Bayar S; Department of Surgical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Ünal AE; Department of Surgical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Int J Clin Pract ; 75(4): e13897, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33280209
PURPOSE: The aim of this study is to evaluate the relation between LVI and molecular subtypes in invasive breast cancers and to find out whether LVI which is a histopathologic indicator has a role in subtype classification or not. METHODS: One hundred and seventy-six patients who had mastectomy for breast cancer between 2013 and 2018 in the Department of Surgical Oncology, Faculty of Medicine, Ankara University were retrospectively analysed. One hundred and thirty-two patients who had LVI, ER, PR, Her 2 and Ki-67 index status information provided in their pathology results were included in the study. The relationship between molecular subtypes and LVI was investigated. RESULTS: One hundred and thirty-two patients were analysed retrospectively. Eighty-two patients had LVI and 50 patients had not. We found a relationship between Luminal B with Her2(-) and LVI, basal like and LVI (P = .00). No significant statistical difference was found between LVI and other molecular subtypes. We confirmed these results with multiple variable analysis (%77.3 correlation). CONCLUSIONS: As a result, we found that LVI can affect molecular subtypes. This showed that a histopathological factor may affect tumour biology. In other words, breast cancer is a heterogeneous disease with many different predictors and prognostic variables.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article